Efficacy and toxicity of antibody-drug conjugates in older adults with breast cancer: A systematic review and meta-analysis.
ADCs efficacy in metastatic breast cancer was similar across age groups, though data in early-stage disease were limited, and insufficient age- and treatment-stratified toxicity reporting precludes meaningful safety assessment of ADCs in older adults with breast cancer.